|
GB201703248D0
|
|
CHK 1 inhibition, synthetic lethality and cancer treatment
|
|
GB201610646D0
|
|
X-ray micro-beam production
|
|
US2015147291A1
|
|
Zinc chelating agents for depleting XIAP and sensitizing tumor cells to apoptosis
|
|
US2015133466A1
|
|
Sensitization of cancer cells to DNA damage by inhibiting kinases essential for DNA damage checkpoint control
|
|
GB201410387D0
|
|
Compounds and their therapeutic use
|
|
US2014080124A1
|
|
Systems and methods for diagnosing a predisposition to develop colon cancer
|
|
US2013303588A1
|
|
Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancer
|
|
US2014275162A1
|
|
Inhibition of leukotriene synthesis and activity in the treatment of sonic hedgehog-associated medulloblastoma
|
|
GB201115554D0
|
|
Imaging method and apparatus
|
|
GB0722272D0
|
|
Improvements in and relating to chaff products and the manufacture thereof
|
|
GB0310596D0
|
|
Method and apparatus for producing an intensity modulated beam of radiation
|
|
US2004005687A1
|
|
Kinase crystal structures
|
|
EP1399412A1
|
|
Photolabile esters and their uses
|
|
AU3818502A
|
|
Binding complexes
|
|
GB0127210D0
|
|
Fail safe rail
|
|
GB0100265D0
|
|
Diphosphine compounds and methods for their preparation
|
|
GB0025912D0
|
|
Materials and methods relating to the treatment of b-cell malignancies
|
|
AU3157799A
|
|
Materials and methods relating to a novel retrovirus
|
|
GB9806649D0
|
|
Materials and methods relating to a novel retrovirus
|
|
WO9502057A1
|
|
Protein tyrosine kinase and ligands thereof
|
